Tag: Alzheimer’s

Presence of Alzheimer disease pathology related to Stages of Objective Memory Impairment in cognitively unimpaired older adults

Class I study shows single doses of aducanumab safe, well tolerated; class II studies show reduced amyloid deposition on brain PET at one year

Graded association seen between levels of cardiorespiratory fitness and incident Alzheimer disease and related disorders

Less than one-quarter of older adults report they would want to take it

Associations consistent across different psychiatric conditions, for Alzheimer disease and all other dementias

Announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year

The Self-Administered Gerocognitive Examination detects the conversion from mild cognitive impairment to dementia sooner than the MMSE

Drug shows promise in clearing brain plaques believed to play a role in Alzheimer disease

Higher baseline coffee consumption also linked to slower Aβ-amyloid accumulation during a 126-month study period as shown on brain MRI scans

Grounds insufficient to offer aducanumab for moderate, advanced Alzheimer dementia or patients without biomarker evidence of brain ß-amyloid